At the higher 1.8 mg daily dose, it lasts about 39 days (roughly five and a half weeks)
The incidence varies considerably between different medications and doses: Semaglutide (Ozempic): Vomiting occurs in approximately 5-10% of patients at diabetes doses Semaglutide (Wegovy): At the higher weight management dose (2.4mg), vomiting affects up to 16% of patients Liraglutide (Victoza): Vomiting affects approximately 5% of patients Liraglutide (Saxenda): At weight management doses, vomiting occurs in about 7-10% of patients Dulaglutide (Trulicity): Vomiting affects approximately 7-9% of patients Tirzepatide (Mounjaro): Vomiting occurs in approximately 5-10% of patients, varying by dose These side effects are most pronounced during the initial treatment phase, particularly in the first 48 weeks, and often diminish as the body adapts to the medication
WVG, Wiss
Used together, they complement each other for recovery, lean muscle, and sleep
(4) Outcome measures: studies were considered for analysis if they reported all complications, adverse events, and serious events
The vigorous back-and-forth motion creates intense shearing forces throughout the liquid and generates foam at the surface
